Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

406 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
In vivo recruitment by painful stimuli of AMPA receptor subunits to the plasma membrane of spinal cord neurons.
Galan A, Laird JM, Cervero F. Galan A, et al. Pain. 2004 Dec;112(3):315-23. doi: 10.1016/j.pain.2004.09.011. Pain. 2004. PMID: 15561387
Painful stimuli induce in vivo phosphorylation and membrane mobilization of mouse spinal cord NKCC1 co-transporter.
Galan A, Cervero F. Galan A, et al. Neuroscience. 2005;133(1):245-52. doi: 10.1016/j.neuroscience.2005.02.025. Epub 2005 Apr 22. Neuroscience. 2005. PMID: 15893647
Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents.
Galan A, Lopez-Garcia JA, Cervero F, Laird JM. Galan A, et al. Neurosci Lett. 2002 Mar 29;322(1):37-40. doi: 10.1016/s0304-3940(02)00078-2. Neurosci Lett. 2002. PMID: 11958838
p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy.
Barcelona PF, Sitaras N, Galan A, Esquiva G, Jmaeff S, Jian Y, Sarunic MV, Cuenca N, Sapieha P, Saragovi HU. Barcelona PF, et al. Among authors: galan a. J Neurosci. 2016 Aug 24;36(34):8826-41. doi: 10.1523/JNEUROSCI.4278-15.2016. J Neurosci. 2016. PMID: 27559166 Free PMC article.
Neuroprotection: Pro-survival and Anti-neurotoxic Mechanisms as Therapeutic Strategies in Neurodegeneration.
Saragovi HU, Galan A, Levin LA. Saragovi HU, et al. Among authors: galan a. Front Cell Neurosci. 2019 Jun 6;13:231. doi: 10.3389/fncel.2019.00231. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31244606 Free PMC article. Review.
Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain.
Galan A, Cervero F, Laird JM. Galan A, et al. Brain Res Mol Brain Res. 2003 Aug 19;116(1-2):126-34. doi: 10.1016/s0169-328x(03)00284-5. Brain Res Mol Brain Res. 2003. PMID: 12941468
Light triggers expression of philanthotoxin-insensitive Ca2+-permeable AMPA receptors in the developing rat retina.
Osswald IK, Galan A, Bowie D. Osswald IK, et al. Among authors: galan a. J Physiol. 2007 Jul 1;582(Pt 1):95-111. doi: 10.1113/jphysiol.2007.127894. Epub 2007 Apr 12. J Physiol. 2007. PMID: 17430992 Free PMC article.
The route of administration influences the therapeutic index of an anti-proNGF neutralizing mAb for experimental treatment of Diabetic Retinopathy.
Barcelona PF, Galan A, Nedev H, Jian Y, Sarunic MV, Saragovi HU. Barcelona PF, et al. Among authors: galan a. PLoS One. 2018 Jun 21;13(6):e0199079. doi: 10.1371/journal.pone.0199079. eCollection 2018. PLoS One. 2018. PMID: 29927948 Free PMC article.
In retinitis pigmentosa TrkC.T1-dependent vectorial Erk activity upregulates glial TNF-α, causing selective neuronal death.
Galán A, Jmaeff S, Barcelona PF, Brahimi F, Sarunic MV, Saragovi HU. Galán A, et al. Cell Death Dis. 2017 Dec 14;8(12):3222. doi: 10.1038/s41419-017-0074-8. Cell Death Dis. 2017. PMID: 29242588 Free PMC article.
Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy.
Galan A, Barcelona PF, Nedev H, Sarunic MV, Jian Y, Saragovi HU. Galan A, et al. Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2852-2862. doi: 10.1167/iovs.16-20988. Invest Ophthalmol Vis Sci. 2017. PMID: 28570737
406 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback